Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model
Authors:
- Jun ChenJCJun Chen
- Bernard L LopezBLBernard L Lopez
- Theodore A ChristopherTCTheodore A Christopher
- Juanli GuJGJuanli Gu
- Paul LyskoPLPaul Lysko
- Robert R RuffoloRRRobert R Ruffolo
- Eliot H OhlsteinEOEliot H Ohlstein
- Xin L MaXMXin L Ma
- Tian-Li YueTYTian-Li Yue
- 1 October 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 406 (1) , 109-116
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of β-Blockers on Free Radical–Induced Cardiac Contractile DysfunctionCirculation, 1999
- Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion modelEuropean Journal of Pharmacology, 1998
- Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial InfarctionCirculation, 1997
- Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic optionsInternational Journal of Cardiology, 1997
- Carvedilol Protects Against Lethal Reperfusion Injury Through Antiadrenergic MechanismsJournal of Cardiovascular Pharmacology, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol: A Novel Multiple Action Antihypertensive Drug that Provides Major Organ ProtectionCardiovascular Drug Reviews, 1994
- Carvedilol, a new vasodilating adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophilsCardiovascular Research, 1994
- SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidantEuropean Journal of Pharmacology, 1994
- Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.Hypertension, 1993